Table 1 Clinical Characteristics of Patients in Group C, D1 and D2

Sex, F/M,n

10(33.33%)/20(66.67%)

5(16.67%)/25(83.33%)

8(26.67%)/22(73.33%)

Age, years

51.50 ± 12.06

50.27 ± 10.06

50.94 ± 9.91

BMI, kg/m²

26.24 ± 2.84

26.09 ± 1.46

25.83 ± 2.23

basic disease(hypertension /DM/CHD), n(%)

7(23.33%)/3(10.00%)/1 (3.33%)

9(30.00%)/2(6.67%)/ 0(0%)

11(36.67%)/2(6.67%)/0(0%)

Type of surgery (radical/ partial), n(%)

14(46.67%)/16 (53.33%)

16(53.33%)/14(46.67%)

14(46.67%)/16(53.33%)

ASA I/II, n(%)

4(13.33%)/26(86.67%)

2(6.67%)/28(93.33%)

1(3.33%)/29(96.67%)

Duration of anaesthesia, min

152.50 ± 63.63

149.67 ± 53.38

143.67 ± 57.63

Duration of surgery, min

134.00 ± 58.63

136.33 ± 53.22

128.83 ± 57.11

Duration of analgesia, min

20.67 ± 12.98

15.50 ± 5.78

17.90 ± 6.32

2%propofol, ml

14.43 ± 1.85

14.73 ± 1.25

14.13 ± 1.36

Rocuronium, mg/h

35.73 ± 6.55

36.26 ± 6.37

37.52 ± 6.55

Sufentanil,μg

34.50 ± 10.45

30.67 ± 1.72

31.50 ± 3.97

Number of using vasoactive agent, n (%)

17 (56.67%)

14 (46.67%)

13 (43.33%)

Postoperative stay in hospital, d

9.40 ± 1.10

8.90 ± 0.85

9.20 ± 0.83